Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

about

Exogenous fatty acid metabolism in bacteria.Staphylococcus aureus utilizes host-derived lipoprotein particles as sources of exogenous fatty acids.Therapeutic Targets in Chlamydial Fatty Acid and Phospholipid Synthesis

P2860

Q39408643-43A425D4-2E04-4BBD-9CB0-B2CF2EACEF10 Q52629550-4251F98B-FD81-49E7-B17D-FC6F952FA2DE Q57492054-D5AAC03F-7230-45AE-AD1F-32703E5AFD4B

P2860

Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

Item

http://www.wikidata.org/entity/Q40334483

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

@en

type

Item

label

Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

@en

prefLabel

Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

@en

P1476

Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

@en

P2093

Charles Soler

http://www.w3.org/2001/XMLSchema#string

Gilles Lamberet

http://www.w3.org/2001/XMLSchema#string

Hoang Vu Thien

http://www.w3.org/2001/XMLSchema#string

Mélanie Guillemet

http://www.w3.org/2001/XMLSchema#string

P2860

Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage

New design platform for malonyl-CoA-acyl carrier protein transacylase

Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus FabI Enzyme–Product Complex

Staphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo Essentiality

Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor

Triclosan promotes Staphylococcus aureus nasal colonization

Triclosan: a widely used biocide and its link to antibiotics

A tale of two functions: enzymatic activity and translational repression by carboxyltransferase.

Waves of resistance: Staphylococcus aureus in the antibiotic era.

Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus.

P31

scholarly article

P356

10.1128/AAC.02515-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28193654

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid

P932

5404599

http://www.w3.org/2001/XMLSchema#string

Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

about

P2860

P2860

Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932